ATE162516T1 - Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren - Google Patents

Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren

Info

Publication number
ATE162516T1
ATE162516T1 AT93920100T AT93920100T ATE162516T1 AT E162516 T1 ATE162516 T1 AT E162516T1 AT 93920100 T AT93920100 T AT 93920100T AT 93920100 T AT93920100 T AT 93920100T AT E162516 T1 ATE162516 T1 AT E162516T1
Authority
AT
Austria
Prior art keywords
metabolizable
tamoxifen
treatment
resistant tumors
clomiphene
Prior art date
Application number
AT93920100T
Other languages
English (en)
Inventor
Alan J Bitonti
Russell J Baumann
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE162516T1 publication Critical patent/ATE162516T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C07C211/48—N-alkylated amines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93920100T 1992-09-15 1993-08-16 Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren ATE162516T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94530592A 1992-09-15 1992-09-15

Publications (1)

Publication Number Publication Date
ATE162516T1 true ATE162516T1 (de) 1998-02-15

Family

ID=25482938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93920100T ATE162516T1 (de) 1992-09-15 1993-08-16 Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren

Country Status (16)

Country Link
US (2) US5410080A (de)
EP (1) EP0660821B1 (de)
JP (1) JPH09500863A (de)
KR (1) KR100326962B1 (de)
AT (1) ATE162516T1 (de)
AU (1) AU672234B2 (de)
CA (1) CA2143000C (de)
DE (1) DE69316633T2 (de)
DK (1) DK0660821T3 (de)
ES (1) ES2112994T3 (de)
FI (1) FI951193L (de)
GR (1) GR3026236T3 (de)
HU (1) HUT71244A (de)
NO (1) NO950985L (de)
NZ (1) NZ255785A (de)
WO (1) WO1994006762A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR008155A1 (es) * 1996-09-06 1999-12-09 Smithkline Beecham Corp Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
DE69840126D1 (de) 1997-08-15 2008-11-27 Univ Duke Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
HK1216502A1 (zh) 2012-11-02 2016-11-18 Repros Therapeutics Inc. 用於癌症治療的反式-克羅米芬
MX2016011567A (es) 2014-03-11 2016-12-07 Repros Therapeutics Inc Sintesis de clomifeno usando un solvente unico.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750416A (en) * 1950-12-21 1956-06-12 Rohm & Haas Aminomethylphenols and method for their preparation
US3143568A (en) * 1961-01-25 1964-08-04 Vismara Francesco Spa Diarylamino-acetyl-aryl derivatives
US3244705A (en) * 1962-11-14 1966-04-05 Richardson Merrell Inc Triphenylhaloethylene derivatives
CH373975A (de) * 1963-07-20 1963-12-15 Heierle Werner Kronen-Verschluss für Flaschen
FR3575M (fr) * 1964-01-28 1965-10-04 Richardson Merrell Triphénylhalogénoéthylenes substitués.
US3631109A (en) * 1968-12-04 1971-12-28 Uniroyal Inc Beta beta'-bis(dialkylaminomethyl-4-hydroxy-benzylthio)dialkylethers
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
DE3762617D1 (de) * 1986-09-11 1990-06-13 Nat Res Dev Tamoxifenderivate.
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors

Also Published As

Publication number Publication date
NZ255785A (en) 1997-05-26
WO1994006762A1 (en) 1994-03-31
KR100326962B1 (ko) 2002-12-02
KR950703524A (ko) 1995-09-20
EP0660821A1 (de) 1995-07-05
FI951193A7 (fi) 1995-03-14
ES2112994T3 (es) 1998-04-16
DE69316633D1 (de) 1998-02-26
AU672234B2 (en) 1996-09-26
CA2143000A1 (en) 1994-03-31
HUT71244A (en) 1995-11-28
JPH09500863A (ja) 1997-01-28
DE69316633T2 (de) 1998-05-20
US5410080A (en) 1995-04-25
FI951193A0 (fi) 1995-03-14
NO950985D0 (no) 1995-03-14
NO950985L (no) 1995-03-14
GR3026236T3 (en) 1998-05-29
US5681863A (en) 1997-10-28
DK0660821T3 (da) 1998-09-21
EP0660821B1 (de) 1998-01-21
FI951193L (fi) 1995-03-14
HU9500775D0 (en) 1995-05-29
CA2143000C (en) 2000-03-28
AU5015093A (en) 1994-04-12

Similar Documents

Publication Publication Date Title
ATE249228T1 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
DE69115297D1 (de) Leukotrien-b4-antagonisten.
KR940005534A (ko) 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
DE69430940D1 (de) Methode zur Behandlung von resistenten Neoplasmen
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ES2154669T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
ATE162516T1 (de) Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren
KR910018383A (ko) 종양성 질환 치료용 엽산염 및 항엽산염과의 디플루오로글루 탐산 공역체
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
ATE99934T1 (de) Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
DE69226487D1 (de) Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten
EP0129891A3 (de) Chinazolinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
ES8605799A1 (es) Procedimiento para la fabricacion de nuevos compuestos cinamoicos
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
DE3277694D1 (en) Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament
DE3770481D1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
EP0097468A3 (de) Thio-naphthotriazole, Verfahren zu ihrer Herstellung und Verwendung bei der Behandlung von Allergien
MY110416A (en) Composition for the treatment of schizophrenia.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee